About Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu
Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu – szpital kliniczny Uniwersytetu Medycznego w Poznaniu. Główną siedzibą szpitala jest zabytkowy kompleks budynków dawnego Zakładu Diakonisek przy ul. Przybyszewskiego 49.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Janssen Research & Development, LLC
6
Pfizer
4
Amgen
3
Celgene
2
Takeda
2
Actelion
1
Boston Scientific Corporation
1
Cortendo AB
1
EMD Serono Research & Development Institute, Inc.
1
Eisai Inc.
1
Clinical Trials at Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu
During the past decade, Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 8 clinical trials were completed, i.e. on
average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
2008-09-01
2011-06-01
Terminated
169
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
2012-01-01
2020-08-31
Completed
428
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
2013-12-03
2017-04-13
Completed
1,320
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma
2016-05-23
2019-06-27
Completed
40
A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma
2017-01-13
2023-07-26
Active, not recruiting
514
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants
2016-10-20
2023-09-02
Active, not recruiting
231
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 6 trials
sponsored, "Pfizer" with 4 trials sponsored, "Amgen" with 3 trials sponsored and "Celgene"
with 3 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu"
#1 collaborator was "Biocompatibles UK Ltd" with 1 trials as a collaborator, "Merck Hellas sa., Greece, an affiliate of Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ovid Therapeutics Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu
According to Clinical.Site data, the most researched conditions in "Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu" are
"Multiple Myeloma" (5 trials), "Multiple Sclerosis" (4 trials), "Chemotherapy-induced Thrombocytopenia" (2 trials), "Epilepsy" (2 trials) and "Melanoma" (2 trials). Many other conditions were trialed in "Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu" in a lesser frequency.
Clinical Trials Intervention Types at Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu
Most popular intervention types in "Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu" are "Drug" (28 trials), "Biological" (2 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Atezolizumab" (4 trials), "Dexamethasone" (4 trials), "Bortezomib" (3 trials) and "Cobimetinib" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu
The vast majority of trials in "Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu" are
35 trials for "All" genders.
Clinical Trials Status at Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu
Currently, there are NaN active trials in "Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu".
undefined are not yet recruiting,
12 are recruiting,
9 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 9 completed trials in Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu, 2 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".